Research Article

Regression of Left Ventricular Hypertrophy in Patients Combined with Peritoneal Dialysis and Hemodialysis

Table 2

Comparison of clinical and laboratory parameters before and after PHD.

Before PHDAfter PHD

Body weight (kg)61.1 ± 9.059.3 ± 8.60.453
SBP (mmHg)141.7 ± 21.8135.5 ± 15.60.002
DBP (mmHg)85.7 ± 7.982.7 ± 8.30.002
Ultrafiltration volume (mL/d)1012 ± 5531233 ± 5310.021
PD1012 ± 553668 ± 222
HD0470 ± 150
iPTH (pg/ml)244 (126, 381)225 (114, 354)0.47
Hb (g/L)96.0 ± 18.4103.3 ± 14.00.001
ALB (g/L)36.1 ± 5.236.4 ± 4.80.38
Ca (mmol/L)2.32 ± 0.162.29 ± 0.160.20
P (mmol/L),1.96 ± 0.541.84 ± 0.49<0.001
BUN (mmol/L)19.2 ± 5.518.7 ± 4.80.24
Scr (umol/L)1209.6 ± 259.41227.8 ± 247.30.54
ESA dosage (104 u/W)4.3 ± 0.43.5 ± 0.3<0.001

SBP, systolic blood pressure; DBP, diastolic blood pressure; iPTH, intact parathyroid hormone; Hb, hemoglobin; ALB, albumin; Ca, calcium; P, phosphorus; BUN, urea nitrogen; Scr, serum creatinine; ESA, erythropoietin stimulating agents.